Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EGFR positive
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
EGFR mutation (196)
EGFR L858R (90)
EGFR T790M (64)
EGFR exon 20 insertion (50)
EGFR wild-type (41)
EGFR L861Q (23)
EGFR C797S (22)
EGFR exon 21 mutation (20)
EGFR L858R + EGFR T790M (16)
EGFR exon 19 mutation (14)
EGFR A763_Y764insFQEA (13)
EGFR G719X (13)
EGFR S768I (12)
EGFR mutation + TP53 mutation (11)
EGFR C797S + EGFR T790M + EGFR L858R (9)
EGFR C797S + EGFR T790M + EGFR exon 19 deletion (9)
EGFR E746_A750del (8)
EGFR exon 20 mutation (8)
EGFRvIII mutation (8)
EGFR G719A (7)
EGFR G719S (7)
EGFR L747P (7)
EGFR exon 18 mutation (7)
EGFR T790M + EGFR C797S (6)
EGFR exon 19 deletion + EGFR L861Q (6)
EGFR mutation + BRAF V600E (6)
EGFR wild-type + ALK wild-type (6)
EGFR G719X + EGFR S768I (5)
EGFR K745_E746insIPVAIK (5)
EGFR G719C (4)
EGFR L861Q + EGFR G719X (4)
EGFR S492R (4)
EGFR mutation + KRAS mutation (4)
EGFR mutation + PIK3CA mutation (4)
EGFR D770 delinsGY (3)
EGFR D770_N771insSVD (3)
EGFR E709K (3)
EGFR E709_T710delinsD (3)
EGFR E746_S752delinsV (3)
EGFR G724S (3)
EGFR H773_V774insH (3)
EGFR L718Q (3)
EGFR L833V + EGFR H835L (3)
EGFR L858R + EGFR M766Q (3)
EGFR R521K (3)
EGFR T790M negative (3)
EGFR T854A (3)
EGFR exon 18-25 duplication (3)
EGFR exon 19 deletion + EGFR C797S (3)
EGFR exon 19 deletion + EGFR T790M + EGFR C797S (3)
EGFR mutation + CREBBP mutation (3)
HER-2 V777L + EGFR L858R (3)
EGFR A767_V769dup (2)
EGFR D761Y (2)
EGFR D770_N771insGT (2)
EGFR E114K (2)
EGFR G465R (2)
EGFR G63R (2)
EGFR G719A + EGFR G779C (2)
EGFR G719C + EGFR S768I (2)
EGFR G719S + EGFR L861Q (2)
EGFR G874S (2)
EGFR H1975 (2)
EGFR K708R (2)
EGFR L747-S752 del (2)
EGFR L747_A750delinsP (2)
EGFR L833F + EGFR L861Q (2)
EGFR L858R + EGFR A871G (2)
EGFR L858R + EGFR L718Q (2)
EGFR L858R + RBM10 Y36* (2)
EGFR L858R + TP53 mutation (2)
EGFR L860R (2)
EGFR L861R (2)
EGFR N771delinsKG (2)
EGFR P596L (2)
EGFR R165Q (2)
EGFR R222C (2)
EGFR S645C + EGFR L858R (2)
EGFR T790M + KRAS mutation (2)
EGFR T790M + PIK3CA H1047R (2)
EGFR V802I + KRAS mutation (2)
EGFR exon 19 duplication (2)
EGFR exon 19 insertion (2)
EGFR exon 20 insertion + EGFR T790M (2)
EGFR mutation + ATM mutation (2)
EGFR mutation + BRAF V600 (2)
EGFR mutation + CDKN2A mutation (2)
EGFR mutation + EGFR T790M (2)
EGFR mutation + MET mutation (2)
EGFR mutation + NRAS Q61K (2)
EGFR mutation + PTEN mutation (2)
EGFR mutation + TP53 mutation + ARID1A mutation (2)
EGFR mutation + TP53 mutation + BRCA1 mutation (2)
EGFR mutation + TP53 mutation + NF1 mutation (2)
EGFR mutation + TP53 mutation + PTEN mutation (2)
EGFR mutation + TP53 mutation + RB1 mutation (2)
EGFR T790L (2)
EGFR delE709_T710insD (2)
KRAS mutation + EGFR wild-type (2)
MET exon 14 mutation + EGFR exon 20 insertion (2)
ALK L1152R + EGFR mutation (1)
ALK rearrangement + ALK T1151M + ALK L1198F + EGFR A839V (1)
ALK rearrangement + EGFR D761N + KRAS V14I (1)
ALK rearrangement + TP53 R175H + EGFR A839V + PI3KCA mutation (1)
BRAF mutation + EGFR mutation (1)
CDK4 mutation + EGFR mutation (1)
DDR + EGFR mutation (1)
EGFR 181946 C>T (1)
EGFR A289V (1)
EGFR A750P (1)
EGFR A763V (1)
EGFR A767_V769dupASV (1)
EGFR A767dupASV (1)
EGFR A859T (1)
EGFR C796S (1)
EGFR C796S + EGFR V802I (1)
EGFR C797S + EGFR C796S (1)
EGFR C797S + EGFR exon 20 insertion (1)
EGFR D770_N771insGL (1)
EGFR D770_N771insGT + EGFR V774_C775insHV (1)
EGFR E690K (1)
EGFR E709A + EGFR G719C (1)
EGFR E709G (1)
EGFR E709Q (1)
EGFR E746 (1)
EGFR E746G (1)
EGFR E746_T751delinsl (1)
EGFR E758D (1)
EGFR E884K (1)
EGFR G2607A (1)
EGFR G709T (1)
EGFR G719A + EGFR I706T (1)
EGFR G719A + EGFR L833V (1)
EGFR G719A + EGFR R776C (1)
EGFR G719A + EGFR S768I (1)
EGFR G719A + EGFR T790M (1)
EGFR G719C + EGFR E709V (1)
EGFR G719D (1)
EGFR G719S + EGFR S768I (1)
EGFR G719X + EGFR E709F (1)
EGFR G719X + EGFR L861Q + EGFR S768I (1)
EGFR G719X + TP53 mutation (1)
EGFR G724S + EGFR R776H (1)
EGFR G735R (1)
EGFR G796S (1)
EGFR G836S (1)
EGFR H773L + EGFR V774M (1)
EGFR H773_V774insNPH (1)
EGFR H773delinsNPY (1)
EGFR H773delinsYNPY (1)
EGFR H835L (1)
EGFR I744_K745insKIPVAI (1)
EGFR K467T (1)
EGFR K757R (1)
EGFR L718V + TP53 V727M + EGFR L858R (1)
EGFR L746_T70delinsS (1)
EGFR L746_T750del (1)
EGFR L747S (1)
EGFR L747_A750>P (1)
EGFR L747_P753delinsS (1)
EGFR L747_T751delinsP (1)
EGFR L747_T751delinsS (1)
EGFR L747_T753delinsS (1)
EGFR L833V (1)
EGFR L8585R + EGFR T790M + RBM10 G840fs*7 (1)
EGFR L858R + ALK R1275Q (1)
EGFR L858R + ALK rearrangement (1)
EGFR L858R + EGFR C797S (1)
EGFR L858R + EGFR D761Y (1)
EGFR L858R + EGFR E709G (1)
EGFR L858R + EGFR E709X (1)
EGFR L858R + EGFR E709X + CTNNB1 mutation (1)
EGFR L858R + EGFR E884K (1)
EGFR L858R + EGFR L747V (1)
EGFR L858R + EGFR R776H (1)
EGFR L858R + EGFR S765I (1)
EGFR L858R + EGFR S768I (1)
EGFR L858R + EGFR T854A (1)
EGFR L858R + EGFR V843I (1)
EGFR L858R + EGFR exon 21 deletion (1)
EGFR L858R + FGF3 mutation (1)
EGFR L858R + IDH1 R132C (1)
EGFR L858R + PIK3CA H1047R + PIK3CA E545K (1)
EGFR L858R + RBM10 2167-1 G>T (1)
EGFR L858R + RBM10 Q255* (1)
EGFR L858R + RBM10 Q595* (1)
EGFR L858R + TP53 R273C + HER-2 S442L (1)
EGFR L858R + TP53 wild-type (1)
EGFR L861P (1)
EGFR L861Q + EGFR exon 20 insertion (1)
EGFR L861Q + TP53 mutation (1)
EGFR L861Q + TP53 mutation + RB1 mutation (1)
EGFR L861X (1)
EGFR M277E (1)
EGFR M766Q (1)
EGFR M766_A767insASV (1)
EGFR N771_P772insH (1)
EGFR N771_P772insVal (1)
EGFR P546S (1)
EGFR P753S (1)
EGFR P772_H773insYNP (1)
EGFR P772_H773insYNP + EGFR H773Y (1)
EGFR P772_V774insPHV (1)
EGFR Q787Q (1)
EGFR R1052K (1)
EGFR R451C (1)
EGFR R776C + EGFR L861Q (1)
EGFR R776H (1)
EGFR R776H + EGFR C797S (1)
EGFR R776H + EGFR L861Q (1)
EGFR S464L (1)
EGFR S720I (1)
EGFR S752_I759del (1)
EGFR S768I + TP53 mutation (1)
EGFR S768_D770dup (1)
EGFR S768_D770dupSVD (1)
EGFR S768dupSVD (1)
EGFR S784F (1)
EGFR T263P (1)
EGFR T751_I759>S (1)
EGFR T790I (1)
EGFR T790M + BRAF V600E (1)
EGFR T790M + EGFR L792F (1)
EGFR T790M + EGFR L833V + EGFR H835L (1)
EGFR T790M + EGFR L861Q (1)
EGFR T790M + EGFR S768I + EGFR L858R (1)
EGFR T790M + HER-2 mutation (1)
EGFR T790M + KRAS G12V (1)
EGFR T790M + MET mutation (1)
EGFR T790M + PARP1 mutation (1)
EGFR T790M + PIK3CA Mutation (1)
EGFR T790M + TP53 R237C (1)
EGFR T854A + EGFR T790M (1)
EGFR T858R (1)
EGFR V769A (1)
EGFR V769_770insASV (1)
EGFR V774_C775insHV (1)
EGFR V786M (1)
EGFR V802I (1)
EGFR V834L (1)
EGFR Y764_V765insHH (1)
EGFR exon 18 mutation + EGFR exon 21 mutation (1)
EGFR exon 19 deletion + ALK mutation (1)
EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)
EGFR exon 19 deletion + BRAF V600E (1)
EGFR exon 19 deletion + BRCA2 mutation (1)
EGFR exon 19 deletion + EGFR G724S + EGFR T790M (1)
EGFR exon 19 deletion + EGFR T790L (1)
EGFR exon 19 deletion + TP53 exon 8 mutation (1)
EGFR exon 19 deletion + TP53 mutation (1)
EGFR exon 19 mutation + EGFR C797S + PIK3CA mutation (1)
EGFR exon 20 insertion + EGFR G719X + EGFR L858R (1)
EGFR exon 20 insertion + NRAS G13V + NF1 R69fs + NF1 S340fs (1)
EGFR exon 20 insertion + TP53 G244A + SPTA1 mutation (1)
EGFR exon 20 mutation + EGFR V774M + EGFR S768I (1)
EGFR exon 21 deletion + EGFR L858R + MET Exon 14 mutation (1)
EGFR exon 21 mutation + EGFR L858R (1)
EGFR mutation + ALK mutation (1)
EGFR mutation + BRAF G469A (1)
EGFR mutation + BRAF mutation + TP53 mutation (1)
EGFR mutation + CTBP2 rs376695472 (1)
EGFR mutation + CTBP2 rs945665113 (1)
EGFR mutation + EGFR T790M + EGFR C797S (1)
EGFR mutation + FAT3 mutation (1)
EGFR mutation + GRM8 mutation (1)
EGFR mutation + HLA-DRB5 rs1071748 (1)
EGFR mutation + HLA-DRB5 rs184278615 (1)
EGFR mutation + HLA-DRB5 rs20146916 (1)
EGFR mutation + IDH1 mutation (1)
EGFR mutation + KIR3DL1 rs199822561 (1)
EGFR mutation + KIR3DL1 rs200821495 (1)
EGFR mutation + KIR3DL1 rs72629105 (1)
EGFR mutation + KIR3DL2 rs973541788 (1)
EGFR mutation + LRP1B mutation (1)
EGFR mutation + MDM4 *32C>A (1)
EGFR mutation + MET Y1003N (1)
EGFR mutation + NOTCH1 mutation (1)
EGFR mutation + RB1 mutation (1)
EGFR mutation + SMAD4 mutation (1)
EGFR mutation + TP53 exon 6 mutation (1)
EGFR mutation + TP53 exon 7 mutation (1)
EGFR mutation + UBXN11 mutation (1)
EGFR mutation + ZNF217 mutation (1)
EGFR mutation+ IDH1 R132H (1)
EGFR rearrangement (1)
EGFR wild-type + ALK wild-type + ROS1 wild-type (1)
EGFR wild-type + ALK wild-type + STK11 mutation (1)
EGFR wild-type + MET wild-type (1)
EGFR-SEPTIN14 rearrangement (1)
EGFR G729A + EGFR L858R (1)
EGFR T790M + TP53 mutation (1)
IDH1 R132C + EGFR L861Q (1)
IDH2 R140W + EGFR L858R (1)
KRAS codon 12 mutation + KRAS codon 13 mutation + EGFR mutation (1)
MTOR L1433S + EGFR L858R + EGFR T790M (1)
EGFR A839V (0)
EGFR E709A (0)
EGFR E709F (0)
EGFR G779C (0)
EGFR G873E (0)
EGFR H773L (0)
EGFR K754E (0)
EGFR L747_S752del (0)
EGFR L747_T750del (0)
EGFR L858R + EGFR G779S (0)
EGFR L858R + RBM10 Q255 (0)
EGFR R776C (0)
EGFR S765I (0)
EGFR T785A + EGFR L861Q + EGFR H297_E298 (0)
EGFR V774M (0)
EGFR mutation + APC mutation (0)
EGFR rs4947492 (0)
MET exon 14 skipping mutation + EGFR G709T (0)
EGFR mutation (196)
EGFR L858R (90)
EGFR T790M (64)
EGFR exon 20 insertion (50)
EGFR wild-type (41)
EGFR L861Q (23)
EGFR C797S (22)
EGFR exon 21 mutation (20)
EGFR L858R + EGFR T790M (16)
EGFR exon 19 mutation (14)
EGFR A763_Y764insFQEA (13)
EGFR G719X (13)
EGFR S768I (12)
EGFR mutation + TP53 mutation (11)
EGFR C797S + EGFR T790M + EGFR L858R (9)
EGFR C797S + EGFR T790M + EGFR exon 19 deletion (9)
EGFR E746_A750del (8)
EGFR exon 20 mutation (8)
EGFRvIII mutation (8)
EGFR G719A (7)
EGFR G719S (7)
EGFR L747P (7)
EGFR exon 18 mutation (7)
EGFR T790M + EGFR C797S (6)
EGFR exon 19 deletion + EGFR L861Q (6)
EGFR mutation + BRAF V600E (6)
EGFR wild-type + ALK wild-type (6)
EGFR G719X + EGFR S768I (5)
EGFR K745_E746insIPVAIK (5)
EGFR G719C (4)
EGFR L861Q + EGFR G719X (4)
EGFR S492R (4)
EGFR mutation + KRAS mutation (4)
EGFR mutation + PIK3CA mutation (4)
EGFR D770 delinsGY (3)
EGFR D770_N771insSVD (3)
EGFR E709K (3)
EGFR E709_T710delinsD (3)
EGFR E746_S752delinsV (3)
EGFR G724S (3)
EGFR H773_V774insH (3)
EGFR L718Q (3)
EGFR L833V + EGFR H835L (3)
EGFR L858R + EGFR M766Q (3)
EGFR R521K (3)
EGFR T790M negative (3)
EGFR T854A (3)
EGFR exon 18-25 duplication (3)
EGFR exon 19 deletion + EGFR C797S (3)
EGFR exon 19 deletion + EGFR T790M + EGFR C797S (3)
EGFR mutation + CREBBP mutation (3)
HER-2 V777L + EGFR L858R (3)
EGFR A767_V769dup (2)
EGFR D761Y (2)
EGFR D770_N771insGT (2)
EGFR E114K (2)
EGFR G465R (2)
EGFR G63R (2)
EGFR G719A + EGFR G779C (2)
EGFR G719C + EGFR S768I (2)
EGFR G719S + EGFR L861Q (2)
EGFR G874S (2)
EGFR H1975 (2)
EGFR K708R (2)
EGFR L747-S752 del (2)
EGFR L747_A750delinsP (2)
EGFR L833F + EGFR L861Q (2)
EGFR L858R + EGFR A871G (2)
EGFR L858R + EGFR L718Q (2)
EGFR L858R + RBM10 Y36* (2)
EGFR L858R + TP53 mutation (2)
EGFR L860R (2)
EGFR L861R (2)
EGFR N771delinsKG (2)
EGFR P596L (2)
EGFR R165Q (2)
EGFR R222C (2)
EGFR S645C + EGFR L858R (2)
EGFR T790M + KRAS mutation (2)
EGFR T790M + PIK3CA H1047R (2)
EGFR V802I + KRAS mutation (2)
EGFR exon 19 duplication (2)
EGFR exon 19 insertion (2)
EGFR exon 20 insertion + EGFR T790M (2)
EGFR mutation + ATM mutation (2)
EGFR mutation + BRAF V600 (2)
EGFR mutation + CDKN2A mutation (2)
EGFR mutation + EGFR T790M (2)
EGFR mutation + MET mutation (2)
EGFR mutation + NRAS Q61K (2)
EGFR mutation + PTEN mutation (2)
EGFR mutation + TP53 mutation + ARID1A mutation (2)
EGFR mutation + TP53 mutation + BRCA1 mutation (2)
EGFR mutation + TP53 mutation + NF1 mutation (2)
EGFR mutation + TP53 mutation + PTEN mutation (2)
EGFR mutation + TP53 mutation + RB1 mutation (2)
EGFR T790L (2)
EGFR delE709_T710insD (2)
KRAS mutation + EGFR wild-type (2)
MET exon 14 mutation + EGFR exon 20 insertion (2)
ALK L1152R + EGFR mutation (1)
ALK rearrangement + ALK T1151M + ALK L1198F + EGFR A839V (1)
ALK rearrangement + EGFR D761N + KRAS V14I (1)
ALK rearrangement + TP53 R175H + EGFR A839V + PI3KCA mutation (1)
BRAF mutation + EGFR mutation (1)
CDK4 mutation + EGFR mutation (1)
DDR + EGFR mutation (1)
EGFR 181946 C>T (1)
EGFR A289V (1)
EGFR A750P (1)
EGFR A763V (1)
EGFR A767_V769dupASV (1)
EGFR A767dupASV (1)
EGFR A859T (1)
EGFR C796S (1)
EGFR C796S + EGFR V802I (1)
EGFR C797S + EGFR C796S (1)
EGFR C797S + EGFR exon 20 insertion (1)
EGFR D770_N771insGL (1)
EGFR D770_N771insGT + EGFR V774_C775insHV (1)
EGFR E690K (1)
EGFR E709A + EGFR G719C (1)
EGFR E709G (1)
EGFR E709Q (1)
EGFR E746 (1)
EGFR E746G (1)
EGFR E746_T751delinsl (1)
EGFR E758D (1)
EGFR E884K (1)
EGFR G2607A (1)
EGFR G709T (1)
EGFR G719A + EGFR I706T (1)
EGFR G719A + EGFR L833V (1)
EGFR G719A + EGFR R776C (1)
EGFR G719A + EGFR S768I (1)
EGFR G719A + EGFR T790M (1)
EGFR G719C + EGFR E709V (1)
EGFR G719D (1)
EGFR G719S + EGFR S768I (1)
EGFR G719X + EGFR E709F (1)
EGFR G719X + EGFR L861Q + EGFR S768I (1)
EGFR G719X + TP53 mutation (1)
EGFR G724S + EGFR R776H (1)
EGFR G735R (1)
EGFR G796S (1)
EGFR G836S (1)
EGFR H773L + EGFR V774M (1)
EGFR H773_V774insNPH (1)
EGFR H773delinsNPY (1)
EGFR H773delinsYNPY (1)
EGFR H835L (1)
EGFR I744_K745insKIPVAI (1)
EGFR K467T (1)
EGFR K757R (1)
EGFR L718V + TP53 V727M + EGFR L858R (1)
EGFR L746_T70delinsS (1)
EGFR L746_T750del (1)
EGFR L747S (1)
EGFR L747_A750>P (1)
EGFR L747_P753delinsS (1)
EGFR L747_T751delinsP (1)
EGFR L747_T751delinsS (1)
EGFR L747_T753delinsS (1)
EGFR L833V (1)
EGFR L8585R + EGFR T790M + RBM10 G840fs*7 (1)
EGFR L858R + ALK R1275Q (1)
EGFR L858R + ALK rearrangement (1)
EGFR L858R + EGFR C797S (1)
EGFR L858R + EGFR D761Y (1)
EGFR L858R + EGFR E709G (1)
EGFR L858R + EGFR E709X (1)
EGFR L858R + EGFR E709X + CTNNB1 mutation (1)
EGFR L858R + EGFR E884K (1)
EGFR L858R + EGFR L747V (1)
EGFR L858R + EGFR R776H (1)
EGFR L858R + EGFR S765I (1)
EGFR L858R + EGFR S768I (1)
EGFR L858R + EGFR T854A (1)
EGFR L858R + EGFR V843I (1)
EGFR L858R + EGFR exon 21 deletion (1)
EGFR L858R + FGF3 mutation (1)
EGFR L858R + IDH1 R132C (1)
EGFR L858R + PIK3CA H1047R + PIK3CA E545K (1)
EGFR L858R + RBM10 2167-1 G>T (1)
EGFR L858R + RBM10 Q255* (1)
EGFR L858R + RBM10 Q595* (1)
EGFR L858R + TP53 R273C + HER-2 S442L (1)
EGFR L858R + TP53 wild-type (1)
EGFR L861P (1)
EGFR L861Q + EGFR exon 20 insertion (1)
EGFR L861Q + TP53 mutation (1)
EGFR L861Q + TP53 mutation + RB1 mutation (1)
EGFR L861X (1)
EGFR M277E (1)
EGFR M766Q (1)
EGFR M766_A767insASV (1)
EGFR N771_P772insH (1)
EGFR N771_P772insVal (1)
EGFR P546S (1)
EGFR P753S (1)
EGFR P772_H773insYNP (1)
EGFR P772_H773insYNP + EGFR H773Y (1)
EGFR P772_V774insPHV (1)
EGFR Q787Q (1)
EGFR R1052K (1)
EGFR R451C (1)
EGFR R776C + EGFR L861Q (1)
EGFR R776H (1)
EGFR R776H + EGFR C797S (1)
EGFR R776H + EGFR L861Q (1)
EGFR S464L (1)
EGFR S720I (1)
EGFR S752_I759del (1)
EGFR S768I + TP53 mutation (1)
EGFR S768_D770dup (1)
EGFR S768_D770dupSVD (1)
EGFR S768dupSVD (1)
EGFR S784F (1)
EGFR T263P (1)
EGFR T751_I759>S (1)
EGFR T790I (1)
EGFR T790M + BRAF V600E (1)
EGFR T790M + EGFR L792F (1)
EGFR T790M + EGFR L833V + EGFR H835L (1)
EGFR T790M + EGFR L861Q (1)
EGFR T790M + EGFR S768I + EGFR L858R (1)
EGFR T790M + HER-2 mutation (1)
EGFR T790M + KRAS G12V (1)
EGFR T790M + MET mutation (1)
EGFR T790M + PARP1 mutation (1)
EGFR T790M + PIK3CA Mutation (1)
EGFR T790M + TP53 R237C (1)
EGFR T854A + EGFR T790M (1)
EGFR T858R (1)
EGFR V769A (1)
EGFR V769_770insASV (1)
EGFR V774_C775insHV (1)
EGFR V786M (1)
EGFR V802I (1)
EGFR V834L (1)
EGFR Y764_V765insHH (1)
EGFR exon 18 mutation + EGFR exon 21 mutation (1)
EGFR exon 19 deletion + ALK mutation (1)
EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)
EGFR exon 19 deletion + BRAF V600E (1)
EGFR exon 19 deletion + BRCA2 mutation (1)
EGFR exon 19 deletion + EGFR G724S + EGFR T790M (1)
EGFR exon 19 deletion + EGFR T790L (1)
EGFR exon 19 deletion + TP53 exon 8 mutation (1)
EGFR exon 19 deletion + TP53 mutation (1)
EGFR exon 19 mutation + EGFR C797S + PIK3CA mutation (1)
EGFR exon 20 insertion + EGFR G719X + EGFR L858R (1)
EGFR exon 20 insertion + NRAS G13V + NF1 R69fs + NF1 S340fs (1)
EGFR exon 20 insertion + TP53 G244A + SPTA1 mutation (1)
EGFR exon 20 mutation + EGFR V774M + EGFR S768I (1)
EGFR exon 21 deletion + EGFR L858R + MET Exon 14 mutation (1)
EGFR exon 21 mutation + EGFR L858R (1)
EGFR mutation + ALK mutation (1)
EGFR mutation + BRAF G469A (1)
EGFR mutation + BRAF mutation + TP53 mutation (1)
EGFR mutation + CTBP2 rs376695472 (1)
EGFR mutation + CTBP2 rs945665113 (1)
EGFR mutation + EGFR T790M + EGFR C797S (1)
EGFR mutation + FAT3 mutation (1)
EGFR mutation + GRM8 mutation (1)
EGFR mutation + HLA-DRB5 rs1071748 (1)
EGFR mutation + HLA-DRB5 rs184278615 (1)
EGFR mutation + HLA-DRB5 rs20146916 (1)
EGFR mutation + IDH1 mutation (1)
EGFR mutation + KIR3DL1 rs199822561 (1)
EGFR mutation + KIR3DL1 rs200821495 (1)
EGFR mutation + KIR3DL1 rs72629105 (1)
EGFR mutation + KIR3DL2 rs973541788 (1)
EGFR mutation + LRP1B mutation (1)
EGFR mutation + MDM4 *32C>A (1)
EGFR mutation + MET Y1003N (1)
EGFR mutation + NOTCH1 mutation (1)
EGFR mutation + RB1 mutation (1)
EGFR mutation + SMAD4 mutation (1)
EGFR mutation + TP53 exon 6 mutation (1)
EGFR mutation + TP53 exon 7 mutation (1)
EGFR mutation + UBXN11 mutation (1)
EGFR mutation + ZNF217 mutation (1)
EGFR mutation+ IDH1 R132H (1)
EGFR rearrangement (1)
EGFR wild-type + ALK wild-type + ROS1 wild-type (1)
EGFR wild-type + ALK wild-type + STK11 mutation (1)
EGFR wild-type + MET wild-type (1)
EGFR-SEPTIN14 rearrangement (1)
EGFR G729A + EGFR L858R (1)
EGFR T790M + TP53 mutation (1)
IDH1 R132C + EGFR L861Q (1)
IDH2 R140W + EGFR L858R (1)
KRAS codon 12 mutation + KRAS codon 13 mutation + EGFR mutation (1)
MTOR L1433S + EGFR L858R + EGFR T790M (1)
EGFR A839V (0)
EGFR E709A (0)
EGFR E709F (0)
EGFR G779C (0)
EGFR G873E (0)
EGFR H773L (0)
EGFR K754E (0)
EGFR L747_S752del (0)
EGFR L747_T750del (0)
EGFR L858R + EGFR G779S (0)
EGFR L858R + RBM10 Q255 (0)
EGFR R776C (0)
EGFR S765I (0)
EGFR T785A + EGFR L861Q + EGFR H297_E298 (0)
EGFR V774M (0)
EGFR mutation + APC mutation (0)
EGFR rs4947492 (0)
MET exon 14 skipping mutation + EGFR G709T (0)
›
Associations
(8)
News
Trials
Search handles
@APassaroMD
@AndresFCardonaZ
@DanZhaoMD
@Dr_Ivanoncologo
@FilippoMontemu1
@HHorinouchi
@JackWestMD
@MARIANOPROVENCI
@MLPOncoData
@SimonLo21054188
@SuyogCancer
@VivekSubbiah
@bpiperdi
@dr_yakupergun
@sujithonco
@weldeiry
Search handles
@APassaroMD
@AndresFCardonaZ
@DanZhaoMD
@Dr_Ivanoncologo
@FilippoMontemu1
@HHorinouchi
@JackWestMD
@MARIANOPROVENCI
@MLPOncoData
@SimonLo21054188
@SuyogCancer
@VivekSubbiah
@bpiperdi
@dr_yakupergun
@sujithonco
@weldeiry
Filter by
Latest
10ms
Targeting both EGFR-positive tumors and PD-1 blockade may result in improved tumor shrinkage, says our Dr. Ann Gillenwater, suggesting further study to assess its potential as a new therapy for recurrent head and neck cancer. https://t.co/8AG8Cdbo05 @OncLive @agillenw #EndCancer (@MDAndersonNews)
10 months ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
10ms
Learn about the realities of treating EGFR positive NSCLC in Brazil from the good to the areas of improvement. @IASLC @StephenVLiu (@NarjustFlorezMD)
10 months ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
10ms
#LungCancerConsidered host @NarjustFlorezMD examines treatment of EGFR-positive #lungcancer in Brazil, from early-stage disease to metastatic lung cancer. W/Dr. Juliana Ominelli (Brazilian National Cancer Institute) & @victormarcondes (Oncomed Oncologia): https://t.co/Fx7NhW5NEV (@IASLC)
10 months ago
Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
10ms
New📰published: AMEERA-3: Randomized Phase II Study of Amcenestrant Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. @stolaney1 and colleagues. https://t.co/QqL6DtT4C7 (@DFCI_BreastOnc)
10 months ago
Clinical • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative • EGFR positive
|
amcenestrant (SAR439859)
12ms
#ASCO Guideline Update on Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer from @DrHBurstein et al #bcsm #MBC #breastcancer (@DFCI_BreastOnc)
12 months ago
Metastases
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 negative • EGFR positive
12ms
Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health Records https://t.co/cudttylMUM (@MLPOncoData)
12 months ago
Clinical • HEOR • Real-world evidence • Real-world • Metastases
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
|
Perjeta (pertuzumab)
1year
@NarjustFlorezMD & @StephenVLiu talk w/@DrRoyHerbstYale about ADAURA Trial, which introduced targeted therapy in the adjuvant setting for early-stage EGFR positive #NSCLC, showing DFS rates never seen before & changing treatment of early-stage #lungcancer. https://t.co/83VEVSYgFc (@IASLC)
1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
1year
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer https://t.co/XAw4xrIpHJ (@MLPOncoData)
1 year ago
Metastases
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 negative • EGFR positive
1year
New systematic review on Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive #BreastCancer and #BrainMetastases from @stolaney1 @volkmar_mueller @nlinmd @FilippoMontemu1 et al Full text⬇️: https://t.co/GTBy56oweT (@DFCI_BreastOnc)
1 year ago
Clinical • Clinical data • Review
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
1year
Optimal duration of adjuvant TKI? @Alfdoc2 kicked off the session truly illustrative case prese ntation! Very relevant situation and question for these patients after complete resection of EGFR positive NSCLC. #ELCC23 #LCSM @myESMO @IASLC (@HHorinouchi)
1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
1year
New📰from @JournalCancer👉Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohorts. @DrAnnaWeiss @TariKingMD @stolaney1 @PTarantinoMD https://t.co/CTl7Rgm4Xf (@DFCI_BreastOnc)
1 year ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
1year
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer An excellent review👇 @CAonline https://t.co/nghZLt5CFe (@dr_yakupergun)
1 year ago
Review • Metastases
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 negative • EGFR positive
1year
⚡️Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts @PTarantinoMD @OncoAlert @JournalCancer @AmericanCancer https://t.co/A7Z2eUraKM (@VivekSubbiah)
1 year ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
1year
At #TTLC23, experts debated the pros and cons of continued TKI use with chemotherapy for EGFR-positive patients with disease progression. Read a recap in #ILCN: https://t.co/bvNZVrSbEV @DrSteveMartin #LCSM (@IASLC)
1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
1year
@JoelNealMD MD, PhD, discussed what options physicians would choose when treating a patient with #NSCLC who tested positive for an EGFR exon 20 insertion. #lcsm | @StanfordMed https://t.co/la7vAWZlF3 (@TargetedOnc)
1 year ago
Clinical • EGFR exon 20
|
EGFR (Epidermal growth factor receptor)
|
EGFR exon 20 insertion • EGFR exon 20 mutation • EGFR positive
1year
Just Published Systematic Literature Review on the Epidemiology, Clinical Outcomes, and Unmet Needs of Patients With Human Epidermal Growth Factor Receptor 2-Positive #BreastCancer and Brain Metastases. @stolaney1 @nlinmd @volkmar_mueller @FilippoMontemu1 https://t.co/6V1NIiQ9sw (@DFCI_BreastOnc)
1 year ago
Clinical • Clinical data • Review
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
1year
Epidemiology, Clinical Outcomes, and Unmet Needs of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: A Systematic Literature Review https://t.co/kMUoXa3eIi I am so sappy to have provided my contribution, with a stellar faculty! (@FilippoMontemu1)
1 year ago
Clinical • Clinical data • Review
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
1year
Showing 1594 in #lungcancer -THIS is what happens to you egfr positive patients when you don’t identify their mutation or just go to #immunotherapy. Like chemo alone says @n8pennell @OncLive @OncLiveSOSS with chair #DrAlexAdjei @ClevelandClinic (@donnashort)
1 year ago
Clinical • IO biomarker
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data | Future Oncology https://t.co/nSW3k53kse (@MARIANOPROVENCI)
over 1 year ago
Clinical • Real-world evidence • Real-world
|
EGFR (Epidermal growth factor receptor)
|
EGFR T790M • EGFR positive
|
Tagrisso (osimertinib)
over1year
A New Year Gift art from a small girl She drew a picture also on doctor's day when her grandmother came to meet me for Follow up. Her grandmother has EGFR positive stage 4 lung cancer and is on Gefitinib since 2yr #KINDNESS #lungcancer (@sujithonco)
over 1 year ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
|
gefitinib
over1year
Don't miss Dr. Sara Tolaney's talk tomorrow at #SABCS22 on Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive (HER2+) #BreastCancer: final 10-year results and correlative analyses. @stolaney1 (@DFCI_BreastOnc)
over 1 year ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
|
Herceptin (trastuzumab) • paclitaxel
over1year
Can IO work post tki progression in egfr positive nsclc ? Nivo trial is negative. What about pembrolizumab ? Time will answer. By @peters_solange @myESMO #ESMOAsia22 @JackWestMD @StephenVLiu (@SuyogCancer)
over 1 year ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
|
Keytruda (pembrolizumab) • Opdivo (nivolumab)
over1year
Prof. Ahn provided important information comparing tissue and liquid NGS in EGFR-positive NSCLC in the ELIOS trial. #ESMOAsia22 #LCSM (@HHorinouchi)
over 1 year ago
Next-generation sequencing
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
Nice discussion covering broad topics in EGFR-positive NSCLC by @Alfdoc2. #ESMOAsia22 #LCSM (@HHorinouchi)
over 1 year ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
Prof. Pasi Jänne provided great summary on novel treatment strategy on EGFR positive NSCLC. Welcome back to Japan after long blank due to COVID-19. @JLCS2022 @JLCS_OFFICIAL #LCSM (@HHorinouchi)
over 1 year ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
PD18-02 Friday @SABCSSanAntonio Adjuvant Paclitaxel and Trastuzumab Trial (APT) for node-negative, human epidermal growth factor receptor 2–positive (HER2+) breast cancer: final 10-year analysis Includes @HER2DX and other correlative analyses! Presenter: @stolaney1 ()
over 1 year ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
|
HER2DX
|
Herceptin (trastuzumab) • paclitaxel
over1year
News: Telisotuzumab vedotin plus erlotinib may offer a novel treatment option for #NSCLC positive for both EGFR and c-Met alterations, report Ross Camidge (@CUCancerCenter) @barlesi @AlexSpiraMDPhD @DavidHongMD et al in @JCO_ASCO https://t.co/7aRiUwEF6f (@MM_Oncology)
over 1 year ago
EGFR (Epidermal growth factor receptor) • MET (MET proto-oncogene, receptor tyrosine kinase)
|
EGFR positive
|
erlotinib • telisotuzumab vedotin (ABBV-399)
over1year
Cancers | Free Full-Text | Management of Brain Metastases from Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Cancer @VenurVyshak @drjenspecht @fredhutch @uwradonc https://t.co/Q0LQIpdpJ9 (@SimonLo21054188)
over 1 year ago
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
over1year
Dr. @ZPiotrowskaMD and I are answering ?s RIGHT NOW over on @LUNGevity's FB page as we talk about advice for patients with EGFR-positive #lungcancer. Join us! https://t.co/cGpPVDD4Oi #LCSM (@acmoorephd)
over 1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
Join me and Dr. @ZPiotrowskaMD TOMORROW at 3 PM ET on @LUNGevity's FB page as we discuss advice for patients newly diagnosed with EGFR-positive #lungcancer #LCSM @EGFRResisters (@acmoorephd)
over 1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
Flaura trial changed the landscape of how we treat egfr positive #lungcancer says Dr Patel with cochairs @DrHaigentz and @SalmaJabbour1 @RutgersCancer @RWJBarnabas @OncLive @OncLiveSOSS #lcsm 80% of patients saw objective response (@donnashort)
over 1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
Join Dr. @ZPiotrowskaMD and me on Sept 22 at 3 pm ET as we discuss advice for patients newly-diagnosed with EGFR-positive #lungcancer. Simply go to @LUNGevity's Facebook page and tune in! @EGFRResisters #LCSM (@acmoorephd)
over 1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR positive
over1year
For PD-L1 positive and EGFR/ALK wild type NSCLC, it is highly possible that neoadjuvant IO is better than adjuvant IO. (@JoeChangMD)
over 1 year ago
Clinical
|
EGFR (Epidermal growth factor receptor) • PD-L1 (Programmed death ligand 1) • ALK (Anaplastic lymphoma kinase)
|
PD-L1 expression • ALK positive • EGFR wild-type • ALK wild-type • EGFR positive
over1year
Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer | Journal of Clinical Oncology @hoperugo @stolaney1 @dradityabardia @JCO_ASCO @ASCO https://t.co/2CXiFk3pwm (@bpiperdi)
over 1 year ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 negative • EGFR positive
|
Trodelvy (sacituzumab govitecan-hziy)
almost2years
Afatinib in front line for uncommon mutations seem to do better for egfr positive #lungcancer says Dr Leighl with moderator @marinagarassino @gotoPER #ilcc #hb @IASLC @GO2Foundation @pmcancercentre @UCCancerCenter #lcsm use NGS (@donnashort)
almost 2 years ago
Next-generation sequencing
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR positive
|
Gilotrif (afatinib)
almost2years
PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer | JCO Precision Oncology https://t.co/UkQvslT2QV (@weldeiry)
almost 2 years ago
HER-2 (Human epidermal growth factor receptor 2) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha)
|
PIK3CA mutation • EGFR positive
almost2years
5 drugs recipe 🥣. FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group https://t.co/q0K5tvozxF (@m_khushman)
almost 2 years ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
EGFR positive
|
Herceptin (trastuzumab) • Perjeta (pertuzumab)
almost2years
Interesting review of #treatment for estrogen receptor-positive/human epidermal growth factor receptor two negative advanced #breastcancer. @oncotoracicamx @JCO_ASCO @aceveher2neu @AndresFCardonaZ @FernandoOnco @genomejunkie https://t.co/ozWrJw1OhD (@Dr_Ivanoncologo)
almost 2 years ago
Review
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • EGFR positive
almost2years
##ASCO22 Is over! #LCSM It was a great, to recap data presented on the EGFR-positive disease, with @MatthewGKrebs @nicogirardcurie & @JSabari for the post-ASCO OME forum. New evidences & results in the fields are really promising (post -Osi resistant & exon20ins disease) (@APassaroMD)
almost 2 years ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
almost2years
Axillary Response to #Neoadjuvant Therapy in Node-Positive, Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative #BreastCancer Patients: Predictors and #OncologicOutcomes https://t.co/xu5rCW8bD9 @Dr_Avisar @umiamimedicine #VisualAbstract @McMastersKelly (@AnnSurgOncol)
almost 2 years ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative • EGFR positive
almost2years
Chaired by @BenjaminBesseMD, experts including VHIO’s @EnriquetaFelip participate in an @ecancer panel discussion on the latest in EGFR positive #NSCLC and data presented at #ASCO22 @ASCO https://t.co/LCWeKRVvus (@VHIO)
almost 2 years ago
EGFR (Epidermal growth factor receptor)
|
EGFR positive
almost2years
I was happy to discuss with @EnriquetaFelip , @Anna_Minchom chaired by @BenjaminBesseMD about the latest news in EGFR positive NSCLC, presented during #ASCO22 @ecancer @EGFRResisters @Exon20Group #LCSM https://t.co/fdaq35VKTT (@APassaroMD)
almost 2 years ago
EGFR exon 20
|
EGFR (Epidermal growth factor receptor)
|
EGFR exon 20 insertion • EGFR exon 20 mutation • EGFR positive
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login